AbbVie taxes slashed as $55B Shire deal sealed

U.S. drug maker AbbVie has agreed to buy Shire Pharmaceuticals in a deal valued at nearly $55 billion.


JOIN THE CONVERSATION

To find out more about Facebook commenting please read the
Conversation Guidelines and FAQs

Leave a Comment